ASH 2021 Conference Coverage on VuMedi

 

ASH 2021 Conference Coverage on VuMedi
Y

ASH 2021 Update on Brexucabtagene Autoleucel for R/R MCL: Real-World Experience From the US Lymphoma CAR T Consortium

By ASH 2021 Conference Coverage on VuMedi FEATURING Yucai Wang
By ASH 2021 Conference Coverage on VuMedi FEATURING Yucai Wang
23 views
December 22, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip
Lymphoma
05:05

A Multi-Institution Analysis of Relapsed Lymphoma Occurring During P…

ASH 2021 Conference Coverage on VuMedi

F. Farooq

15 views
07:23

ASH 2021 Five-Year Follow-Up of Keynote-087: Pembrolizumab Monothera…

ASH 2021 Conference Coverage on VuMedi

A. Herrera

281 views
24:07

ASH 2021 Highlights: CAR-T as 2L Therapy in R/R Aggressive NHL

ASH 2021 Conference Coverage on VuMedi

N. Ahmed

91 views
12:04

ASH 2021 Update on the Safety and Efficacy of CD37-Targeting Naratux…

ASH 2021 Conference Coverage on VuMedi

M. Y. Levy

121 views
14:15

ASH 2021 Update on the Outcomes & Treatment Patterns in Pts With Agg…

ASH 2021 Conference Coverage on VuMedi

J. Zurko

221 views
10:55

ASH 2021 Update on a Phase II Study of OB-VEN in Patients With HTB-F…

ASH 2021 Conference Coverage on VuMedi

C. Portell

76 views
10:52

ASH 2021 Updates on Managing R/R DLBCL: Surveying Treatment Landscape

ASH 2021 Conference Coverage on VuMedi

A. Goy

24 views
09:47

ASH 2021 Update on Brexucabtagene Autoleucel for R/R MCL: Real-World…

ASH 2021 Conference Coverage on VuMedi

Y. Wang

23 views
06:00

ASH 2021 Highlights on Concurrent Pembrolizumab With AVD for Untreat…

ASH 2021 Conference Coverage on VuMedi

R. C. Lynch

82 views
17:50

ASH 2021 Updates on Allogeneic CAR-T PBCAR0191 With Intensified Lymp…

ASH 2021 Conference Coverage on VuMedi

B. Shah

66 views
10:59

ASH 2021: Glofitamab + R-CHOP Induces High Response Rates With Minim…

ASH 2021 Conference Coverage on VuMedi

N. Ghosh

157 views
09:46

ASH 2021 Frontline Treatment With Pembrolizumab Followed by AVD Chem…

ASH 2021 Conference Coverage on VuMedi

P. Allen

243 views
08:18

ASH 2021 Updates on the Umbralisib + Ublituximab Combo in R/R MZL: R…

ASH 2021 Conference Coverage on VuMedi

J. Chavez

63 views
10:20

ASH 2021 Highlights on Real-World Case Studies in ctDNA

ASH 2021 Conference Coverage on VuMedi

P. Blombery

81 views
06:32

ASH 2021 Updates on CD30-Directed CAR T-Cells for Pediatric Patients…

ASH 2021 Conference Coverage on VuMedi

G. Hucks

43 views